MGEN - Miragen Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
4,306
8,386
4,003
3,337
2,538
Cost of Revenue
-
-
-
2,548
2,472
Gross Profit
-
-
-
789
66
Operating Expenses
Research Development
32,983
30,421
19,623
888
1,002
Selling General and Administrative
11,605
11,049
10,912
9,575
10,251
Total Operating Expenses
44,588
41,470
30,535
10,463
11,253
Operating Income or Loss
-40,282
-33,084
-26,532
-9,674
-11,187
Interest Expense
911
873
383
95
141
Total Other Income/Expenses Net
-
-
-
-2,905
0
Income Before Tax
-39,853
-32,703
-26,512
-12,674
-11,328
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-39,853
-32,703
-26,512
-12,674
-11,328
Net Income
-39,853
-32,703
-26,512
-12,674
-11,328
Net Income available to common shareholders
-39,853
-32,703
-26,517
-12,674
-11,328
Reported EPS
Basic
-
-1.10
-1.38
-17.58
-21.00
Diluted
-
-1.10
-1.38
-17.58
-21.00
Weighted average shares outstanding
Basic
-
29,600
19,245
721
539
Diluted
-
29,600
19,245
721
539
EBITDA
-
-31,830
-26,129
-12,390
-11,003